drugset / Trial / NCT01929213

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration

NCT01929213

RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to investigate the pharmacokinetic drug interaction and safety after oral administration of Udenafil(DA-8159) and Bosentan in healthy volunteers. Design: Randomized, open-label, multiple-dose, three-treatment, three-period, six-sequence, Williams design Investigational Product: Udenafil, Bosentan

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosentan Other / unclassified Oral
Subject Udenafil Small molecule Oral

Indications

No indication recorded.